Neuren Media and Analyst Coverage, page-1501

First 1501 Last

Share
Profile

Follow
Grinny

58 Posts.

50

28/01/25

20:33

Post #: 77593617
Share

Originally posted by royalwulff55: ↑

My answer would be that there is obviously a degree of risk plus development costs and time before that value is realised. People's assessment of risk will vary which will influence final value estimates.

But I also think there is a significant element of incredulity at the numbers generated that makes people drop their valuations as for example KJK pointed out with his extraordinary analysis of Hashan de Silva's numbers. I honestly feel that Neuren's business is very poorly understood outside of the inner circle (and I include the rusted on posters present here in that group). If I discuss NEU with anyone who doesn't know the story well I am invariably met with comments like "But aren't these syndromes incredibly rare" or "How many people have these syndromes" or "but it's not curing the disease" etc etc which so miss the point that it is actually laughable. And these are intelligent people making these comments. Make no mistake if NEU was working in eg the cancer space rather than orphan disease and demondstrated the success it has had the share price would be multiples higher.

Time will tell as usual.

Expand

couldnt agree more

NEU Price at posting: $14.39 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

NEU

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

First 1501 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $13.18		Change 0.640(5.10%)		Mkt cap ! $1.640B

Open	High	Low	Value	Volume
$12.96	$14.00	$12.91	$18.41M	1.351M

Buyers (Bids)

No.	Vol.	Price($)
4	305	$13.17

Sellers (Offers)

Price($)	Vol.	No.
$13.20	431	3

View Market Depth

No.	Vol.	Price($)
10	309	13.190
8	252	13.180
6	1089	13.170
4	553	13.160
5	763	13.150

Price($)	Vol.	No.
13.200	187	3
13.210	396	2
13.220	1375	4
13.230	1100	3
13.240	1339	4

Last trade - 15.58pm 26/06/2025 (20 minute delay)

NEU (ASX) Chart

Neuren Media and Analyst Coverage, page-1501

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Neuren Media and Analyst Coverage, page-1501

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Thursday's HotCopper trends: Paradigm's drug IP buy, MTM placement | June 26

Australia’s gas crisis is here – and dying coal plants aren’t helping

'Not possible' to port renewable gas: ACCC takes AGN to court

Neuren jumps over +11% on patent win for Pitt Hopkins drug treatment

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News